Primary lymphoma of the liver - Morphological and clinical analysis of 6 cases. Success of aggressive treatment

Neoplasma

Volumn 52, Issue 3, 2005, Pages 267-272

  Ziarkiewicz Wroblewska B ^a   Gornicka B ^a   Suleiman, W ^a   Wroblewski T ^a   Morton, M ^a   Wilczynski, G M ^a   Heleniak, H ^a   Skwarek, A ^a   Koperski, L ^a   Dudek, K ^a   Krawczyk, M ^a   Jedrzejczak, W W ^a   Dwilewicz Trojaczek, J ^a   Wasiutynski, A ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Extranodal DLBCL; Immunohistochemistiy; Liver lymphoma

Indexed keywords

CARBOPLATIN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; CD59 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IFOSFAMIDE; MYC PROTEIN; PREDNISONE; PROTEIN BAX; PROTEIN BCL 2; RITUXIMAB; TUMOR MARKER; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; LYMPHOMA; MALE; MORPHOLOGY;

EID: 20144367582     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ANTHONY PP, SARSFIELD P, CLARKE TJ. Primary lymphoma of the liver: clinical and pathological features of 10 patients. J Clin Pathol 1990; 43: 1007-1013.
2. ASCOLI WA, LO COCO F, ARTINI M, LEVRERO M, MARTELLI M, NEGRO F. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998; 109: 600-609.
3. AVLONITIS VS, LINOS D. Primary hepatic lymphoma: a review. Eur J Sur 1999; 165: 725-729.
4. BAIREY O, ZIMRA Y, SHAKLAI M, OKON E, RABIZADEH E. Bc12, BcIX, Bax, and Bak expression in short and long lived patients with diffuse large B-cell lymphomas. Clin Cancer Res 1999; 5(10): 2860-2866 (Abstract).
5. BARRANS SL, CARTER I, OVEN RG, DAVIES FE, PATMORE RD et al. Germinal center phenotype and bc12-expression combined with the International Prognostic Index improves patients risk stratification in diffuse large B-cell lymphoma. Blood 2002; 117: 322-332.
6. BORGONOVO G, D'OIRON R, AMATO A, LEGER-RAVET B, ISENI MC et al. Primary lymphoplasmacytic lumphoma of the liver associated with a serum monoclonal peak of IgG kappa. Am J Gastroenterol 1995; 90: 137-140.
7. BRONOWICKI JP, BINEAU C, FEUGIER P, HERMINE O, BROUSSE N et al. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 2003; 37(4): 781-787.
8. CHANG CC, LIU YC, CLEVELAND RP, PERKINS SL. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas. Am J Clin Pathol 2000; 113(4): 512-518.
9. CHOWLA A, MALHI-CHOWLA N, CHIDAMBARAM A, SURICK B. Primary hepatic lymphoma in hepatitis C: case report and review of the literature. Am Surg 1999; 65(9): 881-883.
10. COTRAN RS, KUMAR V, ROBBINS SL. Pathologic basis of disease. Philadelphia, Saunders Company 1994: 35-50.
11. DE VITA VT, BLEICKARDT EW. National Oncology Forum: perspectives for the year 2000. Cancer J 2001; 7 Suppl 1: 12-13.
12. EL-SABROUT R, GRUBER SA. Etiology and pathogenesis of posttransplant tumors: new insights into viral oncogenesis. Ann Transplant 1997; 2: 67-69.
13. GASCOYNE RD, KRAJEWSKA M, KRAJEWSKI S, CONNORS JM, REED JC. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphomas. Blood 1997; 90(8): 3173-3178.
14. GASCOYNE RD. Molecular heterogeneity of diffuse large B-cell lymphoma. Hematol J 2004; 5: 144-148.
15. GASPAROTTO D, DE RE V, BOIOCCHI M. Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma 2002; 43: 747-751.
16. GOLAY J, LAZZARI M, FACCHINETTI V, BERNASCONI S, BORLERI G et al. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. Blood 2001; 98: 3383-3389.
17. GOLAY J, ZAFFARONI L, VACCARI T, LAZZARI M, BORLERI GM et al. Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood 2000; 95: 3900-3908.
18. GÓRNICKA B, ZIARKIEWICZ-WRÓBLEWSKA B, WRÓBLEWSKI T, WILCZYNSKI GM, KOPERSKI L et al. Hepatocellular carcinoma, a fibrolamellar variant - immunohistochemical analysis of 4 cases. (Accepted for publication in Hepato-Gastroenterology).
19. GORTER A, MERI S. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today 1999; 20: 576-582.
20. GRILLO-LOPEZ AJ. Monoclonal antibody therapy for B-cell lymphoma. Int J Hematol 2002; 76(5): 385-393.
21. HARADA S, SUZUKI R, UEHIRA K, YATABE Y, KAGAMI Y et al. Molecular and immunological dissection of DLBCL: CD5+ and CD5- with CD10+ groups may constitute clinically relevant subtypes. Leukemia 1999; 13(9): 1441-1447.
22. ISAACSON PG, BANKS PM, BEST PV, MCLURE SP, MULLER-HERMELINK HK, WYATT JI. Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type. Am J Surg Pathol 1995; 19: 571-575.
23. ISAACSON PG, NORTON AJ. Extranodal lymphomas. New York: Churchil Livingstone, 1996: 1-4 and 294-296.
24. KAWIAK J, ZABEL M. Seminaria z cytofizjologii. Wroclaw: Urban&Partner, 2002: 57-87.
25. KHAN SM, COTTRELL BJ, MILLWARD-SADLER GH, WRIGHT DH. T-cell-reach B-cell lymphoma presenting as liver disease. Histopathology 1993; 23: 217-224.
26. LEI KI. Primary non-Hodgkin's lymphoma of the liver. Leuk Lymphoma 1998; 29: 293-299.
27. LEI KI, CHOW JK, JOHNSON PJ. Aggressive primary hepatic lymphoma in Chinese patients. Cancer 1995; 76: 1336-1343.
28. MACSWEEN RNM, BURT AD, PORTMANN BC, ISHAK KG, SCHEUER PJ, ANTHONY PP. Pathology of the liver. London: Churchil Livingstone, 2002: 854-856.
29. MAES M, DEPARDIEU C, DARGENT JL, HERMANS M, VERHAEGHE JL et al. Primary low-grade B-cell lymphoma occuring in the liver: a study of two cases. J Hepatol 1997; 27: 922-927.
30. MAHER MM, MCDERMOTT SR, FENLON HM, CONROY D, O'KEANE JC et al. Imaging of primary non-Hodgkin lymphoma of the liver. Clin Radiol 2001; 56(4): 295-301.
31. MAZZARO C, ZAGONEL V, MONFARDINI S, TULISSI P, PUSSINI E et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 2001; 94: 544-550.
32. MOHLER M, GUTZLER F, KALLINOWSKI B, GOESER T, STREMMEL W. Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection. Dig Dis Sci 1997; 42: 2241-2245.
33. NAKAMURA N, NAKAMINE H, TAMARU J, NAKAMURA S, YOSHINO T et al. The distinction between Burkitt lymphoma and diffuse large B-cell lymphoma with c-myc rearrangement. Mod Pathol 2002; 15(7): 771-776.
34. OHSAWA M, AOZASA K, HORIUCHI K, KATAOKA M, HIDA J et al. Malignant lymphoma of the liver: report of five cases and review of literature. Dig Dis Sci 1992; 37: 1105-1109.
35. PAGE RD, ROMAGUERA JE, OSBORNE B, MEDEIROS LJ, RODRIGUES J et al. Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer 2001; 92(8): 2023-2029.
36. PAGNANO KB, SILVA MD, VASSALLO J, ARANHA FJ, SAAD ST. Apoptosis-regulating proteins and prognosis in diffuse large B-cell non-Hodgkin's lymphomas. Acta Haematol 2002; 107(1): 29-34.
37. RAWLS RA, VEGA KJ, TROTMAN BW. Small bowel lymphoma. Curr Treat Options Gastroenterol 2003; 6(1): 27-34.
38. RIZZI EB, SCHININA V, CRISTOFARO M, DAVID V, BIBBOLINO C. Non-Hodgkin's lymphoma of the liver in patient with AIDS: sonographic, CT, and MRI findings. J Clin Ultrasound 2001; 29: 125-129.
39. ROSENWALD A, WRIGHT G, CHAN WC, CONNORS JM, CAMPO E et al. Lymphoma/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-cell lymphoma. N Engl J Med 2002; 346: 1937-1947.
40. SATO Y, ITOH F, HAREYAMA M, SATOH M, HINODA Y et al. Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma. J Gastroeneterol 1999; 34: 486-493.
41. STANCU M, JONES D, VEGA F, MEDEIROS L. Peripheral T-cell lymphoma arising in the liver. Am J Clin Pathol 2002; 118: 574-581.
42. ZHANG A, OHSHIMA K, SATO K, KANDA M, SUZUMIYA J et al. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas. Pathol Int 1999; 49(12): 1043-1052.